Abstract
We previously reported that the protective effect of taurine against indomethacin-induced gastric mucosal injury was due to its antioxidant effects which inhibited lipid peroxidation and neutrophil activation. In this sudy, we examined the effect of taurine on reducing the inflammatory parameters of trinitrobenzene sulfonic acid (TNBS)-induced inflammatory bowel disease (IBD) in rats. To induce IBD, rats were given ethanolic TNBS intracolonically. The rats then received 500 mg/kg/day of taurine per orally. The rats were sacrificed one week after IBD induction. Ulceration and inflammation of the distal colon with formation of granuloma in the vehicle-treated IBD rats after two days of administration of TNBS were observed. Treatment with 0.5 g/kg of taurine by the oral route ameliorated colonic damage and decreased the incidence of diarrhea and adhesions. Colon weight (an index of tissue edema) was markedly increased in the IBD rats after adminstration of TNBS, but was significantly lower after taurine treatment. Myeloperoxidase (MPO) activity in the vehicle-treated IBD rats was substantially increased compared with that of the control. The taurine-treated animals showed reduced MPO activity (35% lower) when compared with that of the vehicle-treated animals. Taurine treatment decreased basal and formyl-methionyl leucyl phenylalanine (FMLP) stimulated reactive oxygen generation in colonic tissue of the IBD rat compared with vehicle treatment after one week. These results suggest that administration of taurine reduced the inflammatory parameters in this rat model of IBD by increasing the defenses against oxidative insult.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boughton-Smith, N.K., Wallace, J.L., Morris, G.P., and Whittle, B.J.R., 1988, The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat, Br. J. Pharmacol., 94:65–72.
Buffinton, G.D. and Doe, W.F., 1995, Depleted Mucosal Antioxidant Defences in Inflammatory Bowel Disease, Free Rad. Biol. Med., 19:911–918.
Fukuda, K., Hirai, Y., Yoshida, H., Hakajiman, T., and Usii, T., 1982, Free amino acid content of lymphocytes and granulocytes compared, Clin. Chem., 28:1758–1761.
Green, T., Fellman, J.H., Eicher, A.L., and Pratt, K.J., 1991, Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils, Biochem. Biophys. Acta, 1073:91–97.
Gurujeyalakshmi, G., Iyer, S.N., Hollinger, M.A., and Giri, S.N., 1996, Procollagen Gene Expression is Down-Regulated by Taurine and Niacin at the Transcriptional Level in the Bleomycin Hamster Model of Lung Fibrosis, J. Pharm. Exp. Ther., 277:1152–1157.
Kim, C.K., Park, E.K., Quinn, M.R., and Schuller-Levis, G., 1996, The production of Superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-α in the conditioned media is inhibited by taurine chloramine, Immunopharm, 34:89–95.
Krawisz, J.E., Sharon, P., and Stenson, W.F., 1984, Quantitative assay for acute intestinal inflammation based on myeloperoxydase activity. Assessment of inflammation in rat and hamster models, Gastroenterology, 87:1344–1350.
MaLoughlin, D.M., Stapleton, P.P., and Bloomfield, F. J., 1991, Influence of Taurine and a substituted taurine on the respiratory burst pathway in the inflammatory response, Biochem. Soc. Trans., 19:73–78.
McKenzie, S.J., Baker, M.S., Buffinton, G.D., and Doe, W.F., 1996, Evidence of Oxidant induced Injury to Epithelial Cells during Inflammatory Bowel Disease, J. Clin. Invest., 98:136–141.
Morris, G.P., Beck, P.L., Herridge, W., Szewczuk, MR., and Wallace, J.L., 1989, Hapten-induced model of chronic inflammation and ulceration in the rat colon, Gastren-terrolgy, 96:759–803.
Murakami, M, Asgoe, K., Dekigai, H., Kusaka, S., Saita, H., and Kita, T., 1995, Products of nuetrophil metabolism increase ammonia-induced gatric mucosal damage, Dig. Dis. Sci., 40:268–273.
Nielsen, O.H., Berild, D., and Ahnfelt-Ronne, I., 1994, In vitro Superoxide production by peripheral neutrophils from patients with inflammatory bowel disease, Mediat. Inflam., 3:161–164.
Pfeiffer, C.J., and Qiu, B.S., 1995, Effects of Chronic Nitric Oxide Synthase Inhibition on TNB-induced Colitis in Rats, J. Pharm. Pharmacol, 47:827–832.
Quinn, M.R., Park, E.K., and Schuller-Levis, G., 1996, Taurine chloramine inhibits prostaglandin E2 production in activated raw 264.7 cells by post-transcriptional effects on inducible cyclooxygenase expression, Immunol Letters, 50:185–188.
Sartor, R.B., 1994, Cytokines in intestinal inflammation: pathophysiological and clinical considerations, Gastroenterology, 106:533–539.
Schuller-Levis, G., Quinn, MR., Wright, C., and Park, E., 1994, Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action in: Taurine in Health and Disease, R Huxtable, Ed, New York, NY: Pleum Press, pp 31–39.
Sharon, P. and Stenson, W.F., 1984, Enhanced synthesis of leukotriene B4 by colonie mucosa in inflammatory bowel disease, Gastroenterology, 86:453–460.
Simmonds, N.J., Allen, C.R., Stevens, T.R., Van Someren, R.N.M., Blake, D.R., and Rampton, D.S., 1992, Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease, Gastroenterology, 103:186–196.
Son, M., Kim, H.K., Kim, W.B., Yang, J., and Kim, B.K., 1996, Protective effect of taurine on indomethacin-induced gastric mucosal injury in: “Taurine 2”, Huxtable, R.J., Azuma, J., Kuriyama, K., Nakagawa, M., and Baba, A., eds, Plenum Press, NY. pp: 147–155.
Stapleton, P.P., Molloy, A.M., Rogers, S., and Bloomfield, F.J., 1996, Neutrophil taurine in psoriasis, Ir. J. Med. Sci., 165:173–176.
Tamai, H., Kachur, J.F., Grisham, M.B., and Gaginella, T.S., 1991, Scavenging Effect of 5-Aminosalicylic Acid on Neutrophil-Derived Oxidants: Possible Contribution to the Mechanism of Action in Inflammatory Bowel Disease, Biochem. Pharm., 41:1001–1006.
Test, S.T., Lampert, M.P., Ossanna, P.J., Thoene, J.G., and Weiss, S.J., 1984, Generation of nitrogenchlorine oxidants by human phagocytes, J. Clin. Invest. 74:1341–1349.
Wang, Q., Giri, S.N., Hyde, D.M., and Nakashima, J.M., 1989, Effects of Taurine on Bleomycin-Induced Lung Fibrosis in Hamsters, Proc. Soc. Exp. Biol. Med. 190:330–338.
Whittle, B.J.R., 1981, Temporal relationship between cyclooxygenase inhibition measured as prostacyclin biosynthesis and gastrointestinal damage induced by indomethacin in the rat, Gastroenterology, 80:94–98.
Wright, C.E., Lin, T.T., Lin, Y.Y., Sturman, J., and Gaull, G., 1985, Taurine scavenges oxidized chlorine in biological systems, Prog. Clin. Biol. Res. 179:113–123.
Yamada, T. and Grisham, M.B., 1991, Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation, Klin Wochenschift 69:988–944.
Yue, G., Sun, F.F., Dunn, C., Yin, K., and Wong, P.Y.K., 1996, The 21-Aminosteroid Tirilazad Mesylate Can Ameliorate Inflammatory Bowel Disease in Rats, J. Pharm. Exp. Ther., 276:265–270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Son, M., Ko, J.I., Kim, W.B., Kang, H.K., Kim, B.K. (1998). Taurine Can Ameliorate Inflammatory Bowel Disease in Rats. In: Schaffer, S., Lombardini, J.B., Huxtable, R.J. (eds) Taurine 3. Advances in Experimental Medicine and Biology, vol 442. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0117-0_37
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0117-0_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0119-4
Online ISBN: 978-1-4899-0117-0
eBook Packages: Springer Book Archive